IMU 1.82% 5.6¢ imugene limited

Media Thread, page-14741

  1. 6,662 Posts.
    lightbulb Created with Sketch. 4375
    From the article, it reads that this is in direct competition to Amgen. Imagine if the OnCarlytics/Blincyto trial yield similar or better results. Amgen would certainly pounce and help IMU to get this through FDA.

    Competition like this is what drives BP to act. After all, the solid tumour market is huge. And nobody wants to be left behind.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.6¢
Change
0.001(1.82%)
Mkt cap ! $411.5M
Open High Low Value Volume
5.5¢ 5.7¢ 5.3¢ $731.7K 13.32M

Buyers (Bids)

No. Vol. Price($)
5 580359 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 686331 5
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.